NDA Peer-Review Process Suggested To FDA By Merck's Scolnick
This article was originally published in The Tan Sheet
Executive Summary
FDA should use outside peer review to aid in the scientific assessment of product applications, Merck Research Laboratories President Edward Scolnick, MD, recommended to FDA's Science Board.